Role of CPAP in Managing Preterm Infants with RDS

Abstract

Respiratory Distress Syndrome (RDS) stands as the main trigger for preterm infant mortality and morbidity because of insufficient surfactant and unready lungs of premature babies. CPAP has become one of the fundamental treatment modalities which simultaneously decreases pathological lung collapse and prevents injuries caused by ventilator use and promotes better oxygen levels. Research was conducted at Albatool Teaching Hospital to assess CPAP effectiveness for preterm babies (<37 weeks) with RDS during two months. This research showed respiratory improvements while pneumothorax affected 50% of cases and provoked pulmonary restriction in 46% of subjects. The findings showed no meaningful relationship between PROM and pneumothorax and adverse outcomes because optimized CPAP protocols effectively reduced complications (*p* = 0.685 and *p* = 0.256 respectively). Birth weights for subjects amounted to 1.687 ± 0.484 kilograms while gestational durations averaged 31.7 ± 2.71 weeks as established in worldwide RDS data. Subjects whose mothers had an average age of 30.62 ± 7.33 years did not demonstrate any relationship between maternal age and RDS outcome severity. The study demonstrates that standardized CPAP protocols hold a vital position in enhancing patient results especially within settings with limited resources while researchers should explore customized CPAP techniques.